NYSE:QGENLife Sciences
Qiagen (QGEN) Stock Could Be 15.7% Undervalued After QIAcuity Expansion
Qiagen (NYSE:QGEN) is in focus after announcing new additions to its QIAcuity digital PCR ecosystem, including expanded gene expression tools, higher multiplexing and upgraded software and automation for high throughput labs.
See our latest analysis for Qiagen.
The QIAcuity update comes as Qiagen’s share price has shown mixed momentum, with a 1-month share price return of 5.06%, a year-to-date share price return that is down 22.32%, and a 5-year total shareholder return that is down 23.67%...